• 1. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 2. Etching of glass microchips with supercritical water?
  Pavel Karásek,Jakub Grym,Michal Roth,Josef Planeta,Franti?ek Foret Lab Chip, 2015,15, 311-318
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Excited-state proton-coupled electron transfer within ion pairs?
  Gerald J. Meyer,Leif Hammarstr?m Chem. Sci., 2020,11, 3460-3473
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams Imidolactams
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidolactams

Research Brief on 3-amino-1-(3-hydroxypropyl)pyrazole (CAS: 1003011-38-8): Recent Advances and Applications in Chemical Biology and Medicine

3-amino-1-(3-hydroxypropyl)pyrazole (CAS: 1003011-38-8) is a pyrazole derivative that has garnered significant attention in recent years due to its versatile applications in chemical biology and medicinal chemistry. This compound serves as a key intermediate in the synthesis of various biologically active molecules, including kinase inhibitors, anti-inflammatory agents, and anticancer drugs. Recent studies have highlighted its potential in modulating enzymatic activity and interacting with specific protein targets, making it a valuable scaffold for drug discovery and development.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers explored the structural optimization of 3-amino-1-(3-hydroxypropyl)pyrazole to enhance its binding affinity for cyclin-dependent kinases (CDKs). The study demonstrated that modifications at the 3-hydroxypropyl moiety could significantly improve selectivity towards CDK4/6, which are critical targets in cancer therapy. The findings suggest that this compound could serve as a promising lead for the development of next-generation CDK inhibitors with reduced off-target effects.

Another recent investigation, featured in Bioorganic & Medicinal Chemistry Letters, focused on the anti-inflammatory properties of 3-amino-1-(3-hydroxypropyl)pyrazole derivatives. The researchers synthesized a series of analogs and evaluated their ability to inhibit pro-inflammatory cytokines such as TNF-α and IL-6. The results indicated that certain derivatives exhibited potent activity, with IC50 values in the low micromolar range, suggesting their potential as novel anti-inflammatory agents.

Beyond its therapeutic applications, 3-amino-1-(3-hydroxypropyl)pyrazole has also been employed in chemical biology as a tool compound. A 2022 study in ACS Chemical Biology utilized this molecule as a fluorescent probe to study protein-ligand interactions in real time. The compound's unique photophysical properties enabled researchers to monitor binding events with high sensitivity, providing insights into the dynamics of enzyme inhibition.

In conclusion, 3-amino-1-(3-hydroxypropyl)pyrazole (CAS: 1003011-38-8) continues to be a focal point of research in chemical biology and medicine. Its versatility as a synthetic intermediate, combined with its biological activity, positions it as a valuable asset in drug discovery and biochemical studies. Future research directions may include further structural optimization, exploration of new therapeutic targets, and development of advanced diagnostic tools based on its unique properties.

• 73616-25-8(1-Butyl-1H-pyrazol-3-amine)
• 956393-73-0(1-Propyl-1H-pyrazol-3-amine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)